Trial
NCT04396535
Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Mayo Clinic
Collaborators
—
Condition
Advanced Lung Non-Small Cell Carcinoma
Intervention
Bintrafusp Alfa
Why stopped
EMD Serono recommendation based on three other studies that failed to show benefit for bintrafusp alfa
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-17